Clinical Trials
3
Active:0
Completed:3
Trial Phases
2 Phases
Phase 1:1
Phase 2:2
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (3 trials with phase data)• Click on a phase to view related trials
Phase 2
2 (66.7%)Phase 1
1 (33.3%)Multi-center Study to Assess Safety, Tolerability and Efficacy of Topical Pravibismane in Moderate DFI Patients
Phase 2
Completed
- Conditions
- Diabetic Foot InfectionDiabetic Foot
- Interventions
- Other: Standard of Care
- First Posted Date
- 2022-01-03
- Last Posted Date
- 2024-11-04
- Lead Sponsor
- Microbion Corporation
- Target Recruit Count
- 47
- Registration Number
- NCT05174806
- Locations
- 🇺🇸
Limb Preservation Platform, Inc., Fresno, California, United States
🇺🇸Parkland Comprehensive Wound Center, Dallas, Texas, United States
🇺🇸Parkland Memorial Hospital, Dallas, Texas, United States
A Trial to Assess Safety and Efficacy of Topical MBN-101 in Patients With Moderate/ Severe DFI
- First Posted Date
- 2016-03-30
- Last Posted Date
- 2020-07-02
- Lead Sponsor
- Microbion Corporation
- Target Recruit Count
- 52
- Registration Number
- NCT02723539
- Locations
- 🇺🇸
Limb Preservation Platform, Inc, Fresno, California, United States
🇺🇸Futuro Clinical Trials, LLC, McAllen, Texas, United States
Study to Assess Safety and Clinical Activity of Local MBN-101 in Treatment of Infected Bone Sites
- First Posted Date
- 2015-05-07
- Last Posted Date
- 2021-09-30
- Lead Sponsor
- Microbion Corporation
- Target Recruit Count
- 29
- Registration Number
- NCT02436876
- Locations
- 🇺🇸
Orthopedic Trauma Institute, University of California San Francisco, San Francisco, California, United States
🇺🇸UCSF - Parnassus, San Francisco, California, United States
🇺🇸LifeBridge Health, Inc., Baltimore, Maryland, United States
News
No news found